Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

AegisCN LLC
Profile last edited on: 2/5/24      CAGE: 6TSU8      UEI: QJP4ZB4KN3B3

Business Identifier: Technologies and treatments targeting neurological diseases and inflammation
Year Founded
2012
First Award
2018
Latest Award
2023
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

3225 Surrey Road Suite C
Durham, NC 27707
   (191) 984-77967
   N/A
   www.aegiscn.com
Location: Single
Congr. District: 02
County: Wake

Public Profile

With assembly of a team of highly skilled and well-credentialed players associates to the firm in some capacity, any form of specific analysis of what AegisCN (as a specific firm) is about is proving more difficult than one would normally expect.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
1
Conversion Rate
100.00%
Phase I Dollars
$227,501
Phase II Dollars
$562,291
Total Awarded
$789,792

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2023 2 NIH $789,792
Project Title: CN-105 Improves Functional Outcome After Intracranial Hemorrhage

Key People / Management

  Hana Dawson

  Robert T Fremeau -- VP of R&D

  Bradley Knolls

  Daniel Laskowitz

  Maureen Maughan -- Vice President Drug Development

  Lanty Smith

Company News

There are no news available.